UPDATE: Investors welcome Lechleiter to Lilly helm
Investors gave an initially favorable response to the news that John C. Lechleiter, a chemist by training, will take the helm of Eli Lilly and Co. next year, at a time the entire industry faces wrenching changes. “I’m all for the person with the science background to be the CEO,” said Rich Foran, vice president […]